Say Hello to BrainGuide

Our new platform BrainGuide™ was featured on Good Morning America. It empowers people of all ages and communities to understand and take action on brain health and Alzheimer's disease.

Aducanumab and UsAgainstAlzheimer's

Aducanumab is a proposed treatment for early Alzheimer’s disease that is intended to slow the progression of the disease. UsAgainstAlzheimer’s (UsA2) has urged the U.S. Food and Drug Administration to approve aducanumab.

UsAgainstAlzheimer’s Survey Shows Alzheimer’s Patients Value a New Therapy that Slows Progression of Symptoms

New survey results from UsAgainstAlzheimer’s A-LIST shows that patients want FDA to weigh willingness of people with MCI/mild Alzheimer’s to take a disease-modifying therapy.

Paid Leave Alliance for Dementia Caregivers Applauds American Rescue Plan but Urges Action on Paid Leave Support for Caregivers

The Paid Leave Alliance for Dementia Caregivers commends the Biden-Harris for making support for working families a top priority in its $1.9 trillion COVID-19 economic relief proposal but urges the administration to clarify how the proposal's paid leave expansions will cover Americans who care for older adults.

UsAgainstAlzheimer’s Commends Apple and Biogen for New Research on Monitoring Brain Health

UsAgainstAlzheimer’s commends Apple and Biogen for their investment in brain health research and working towards creating innovative technologies that would allow consumers to be more aware and in control of their brain health.

Say Hello to BrainGuide

Aducanumab and UsAgainstAlzheimer's

UsAgainstAlzheimer’s Survey Shows Alzheimer’s Patients Value a New Therapy that Slows Progression of Symptoms

Paid Leave Alliance for Dementia Caregivers Applauds American Rescue Plan but Urges Action on Paid Leave Support for Caregivers

UsAgainstAlzheimer’s Commends Apple and Biogen for New Research on Monitoring Brain Health

UsAgainstAlzheimer's: Working to End Alzheimer's Disease  

The Alzheimer’s pandemic is the health and social economic crisis of this generation. It is a national and global emergency that has a devastating health, social and economic toll on millions of people living with this disease, their families and caregivers.

UsAgainstAlzheimer’s exists to conquer Alzheimer’s disease. Since our founding in 2010, we have taken on the toughest problems in the fight to end Alzheimer’s. Our work is driven by the urgency to find effective treatments and the prevention steps needed to reach the time where no one is lost to Alzheimer’s.

We bring all of “Us” together to:

In the past decade, progress has been made, with more hope on the horizon now than ever before.

But every day of delay is another day lost to the millions of people affected by this devastating disease. If nothing changes, by 2050, 14 million Americans will be living with Alzheimer’s at an annual cost of more than $1 trillion. The time to act is now.

Recent News and Blog Posts

  • October 29, 2020

    UsAgainstAlzheimer’s Statement on Exciting Development with New Blood Test to Help in Evaluating Patients for Alzheimer’s

    UsAgainstAlzheimer’s issued the following statement by George Vradenburg, chairman and co-founder, on...

    Read more
  • October 28, 2020

    Continuing Severe Stress for Alzheimer’s Caregivers During Pandemic Now Combined with Worries about COVID-19 Effects on Upcoming Holidays

    A new UsAgainstAlzheimer’s A-LIST® survey of the Alzheimer’s community shows a tough...

    Read more
  • Virginia Biggar

    COVID-19 and Dementia: Lessons for the Next Pandemic

    People with dementia and care partners are among those hardest hit by...

    Read more
  • Virginia Biggar

    COVID-19 and Dementia: Imagining the Future with a Vaccine

    With the national conversation focused on when a vaccine for COVID-19 might...

    Read more
  • Q&A with UsA2 Brain Health Equity Intern Sofia Arraut

    During Hispanic Heritage Month, we have been featuring researchers, civil rights leaders...

    Read more
  • A-LIST Pulse of the Community (Archive 2018-2020)

    Read more

Reports

  • Resources
    Thumbnail

    A-LIST Pulse of the Community: Volume 7, December 2020

    The UsAgainstAlzheimer’s A-LIST® is an online community of more than 8,000 people living with Alzheimer’s and other dementias, current and former caregivers, and those concerned about brain health, who have...

  • Resources
    Thumbnail

    Place & Brain Health Equity: Understanding the County-Level Impacts of Alzheimer’s

    The effects of where people live, and the social determinants of health are under-recognized and under-appreciated in our national response to effectively treat and prevent Alzheimer’s. This report found that...

  • Resources
    Thumbnail

    2019 Annual Report

    In these pages, you will find highlights of the game-changing accomplishments and tremendous progress of UsAgainstAlzheimer's and our partners in the year of 2019.